Folliculitis decalvans associated with erlotinib.
Hoekzema
R
R
Drillenburg
P
P
D000505:Alopecia / Q000139:chemically induced*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy; D000069347:Erlotinib Hydrochloride; D005260:Female; D005499:Folliculitis / Q000139:chemically induced* / Q000188:drug therapy; D006801:Humans; D008875:Middle Aged; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*; D011799:Quinazolines / Q000009:adverse effects*; D013211:Staphylococcus aureus
D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride